InvestorGlobal investment community for angel investors and venture capitalists.

FundPlus is a Belgian private foundation focused on long-term equity investments in innovative life sciences companies, primarily in therapeutics, diagnostics, and medical devices. It aims to create sustainable shareholder value and contribute to the life sciences sector.
Online destinations
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Pages the organization runs itself.
FundPlus is a private foundation established in May 2015 by Désiré Collen and the non-profit organization Life Sciences Research Partners. Based in Leuven, Belgium, it operates as a Belgian Naamloze Vennootschap/Société Anonyme (NV/SA). FundPlus focuses on long-term equity investments in innovative life sciences companies, primarily in therapeutics, diagnostics, and medical devices. The fund aims to create sustainable shareholder value and contribute to the development of the life sciences sector while generating a beneficial societal impact. As of now, FundPlus has raised €200 million in financing commitments.
Fund+ invests in innovative life sciences companies that are primarily active in therapeutics, diagnostics, and medical devices. The fund targets companies seeking Series A or B financing that have already achieved proof of concept. The intended investment size per company ranges from €5 million to €15 million, distributed over various milestones. Fund+ aims to be a significant minority shareholder (more than 10%) and plays a constructive role as a board member in its portfolio companies, focusing on investments in Europe, particularly Belgium.
Fund+ adds value to its portfolio companies by taking significant minority stakes and actively participating as board members, providing strategic guidance and support to help them achieve their milestones and grow sustainably.
FundPlus invests in innovative life sciences companies primarily in therapeutics, diagnostics, and medical devices. They target Series A and B financing for companies that have achieved proof of concept.
Founders can pitch to FundPlus by sending an email to info@fundplus.be. It is advisable to include a detailed business plan and financial projections in the pitch.
FundPlus distinguishes itself through its commitment to societal impact alongside shareholder value. The firm actively participates as a board member in its portfolio companies, providing strategic guidance and support.
FundPlus primarily focuses on investments in Europe, with a strong emphasis on Belgium. This regional focus allows them to leverage local expertise and networks.
FundPlus has raised €200 million in financing commitments, with typical check sizes ranging from €5 million to €15 million per investment.
FundPlus takes significant minority stakes in its portfolio companies and plays an active role as a board member, helping guide strategic decisions and support growth initiatives.
Superscout Pro
Is this page right?Reviewed · How the research works